{"id":"W2958159650","doi":"10.1016/j.cgh.2019.07.010","title":"Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries","year":2019,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Janssen Biotech; Guangdong Provincial Pearl River Talents Program; AbbVie; Johnson and Johnson; Ministry of Science and Technology of the People's Republic of China; Bristol-Myers Squibb Canada; Gilead Sciences; Novartis; Roche; Merck; GlaxoSmithKline; Allergan; Bristol-Myers Squibb","keywords":"Entecavir; Medicine; Hepatocellular carcinoma; Hazard ratio; Internal medicine; Hepatitis B virus; Hepatitis B; Adverse effect; Randomized controlled trial; Liver disease; Gastroenterology; Oncology; Immunology; Confidence interval; Virus; Lamivudine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003732308,0.000203126,0.002581005,0.0001225255,0.00001731902,0.00000186303,0.00004767459,0.0002333854,0.0003769595],"category_scores_gemma":[0.0001781801,0.0001204298,0.0002077495,0.00004374199,0.0009713881,0.00003211777,0.0000432121,0.0001564402,0.00001346553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006084767,"about_ca_system_score_gemma":0.0001025644,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001567433,"about_ca_topic_score_gemma":0.02697595,"domain_scores_codex":[0.9975998,0.0006244666,0.001072899,0.0003418245,0.00009602096,0.0002650316],"domain_scores_gemma":[0.9980996,0.001122424,0.0004076026,0.0002472707,0.00005891877,0.00006417894],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4277505,0.000821266,0.5702198,0.00004001423,0.0007377239,0.00003602032,0.00008587458,2.917921e-7,0.000004533879,0.00001683812,0.000009340712,0.0002778176],"study_design_scores_gemma":[0.4149944,0.0133133,0.571125,0.0000560755,0.0003088903,0.00001780863,0.000003554697,0.00003401169,0.00002230803,0.00001664353,0.00007391861,0.0000340888],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997039,0.0002667357,0.00009288632,0.0005314134,0.0005618541,0.00143482,0.00002764274,0.00001419666,0.00003140768],"genre_scores_gemma":[0.9967908,0.002267127,0.00008986452,0.0005305671,0.00006843184,0.0001109254,0.00001638884,0.00001237679,0.0001135168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02540852,"threshold_uncertainty_score":0.9907792,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04985732964424132,"score_gpt":0.3716480199964852,"score_spread":0.3217906903522438,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}